Supreme Court Opinions

Sripetch v. SEC

30 min · 7 jun 2026
aflevering Sripetch v. SEC artwork

Beschrijving

Welcome to Supreme Court Opinions. In this episode, you’ll hear the Court’s opinion in Sripetch v SEC. In this case, the court considered this issue: May the SEC seek equitable disgorgement under 15 U.S.C. §§ 78u(d)(5) and (d)(7) without showing investors suffered pecuniary harm?  The case was decided on June 4, 2026.  The opinion is presented here in its entirety, but with citations omitted. If you appreciate this episode, please subscribe. Thank you.

Reacties

0

Wees de eerste die een reactie plaatst

Meld je nu aan en word lid van de Supreme Court Opinions community!

Probeer gratis

Probeer 14 dagen gratis

€ 9,99 / maand na proefperiode. · Elk moment opzegbaar.

  • Podcasts die je alleen op Podimo hoort
  • 20 uur luisterboeken / maand
  • Gratis podcasts

Alle afleveringen

257 afleveringen

aflevering Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. artwork

Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc.

Welcome to Supreme Court Opinions. In this episode, you’ll hear the Court’s opinion in Hikma Pharmaceuticals USA Inc. v Amarin Pharma, Inc. In this case, the court considered these issues. 1. When a generic drug manufacturer excludes a patented use from its label, can it still be liable for inducing infringement if it calls its product a “generic version” of the brand-name drug and cites publicly available information about the brand-name drug’s sales? 2. Can a patent infringement complaint survive dismissal if it does not allege that the defendant made any statement specifically instructing or encouraging the patented use? The case was decided on June 4, 2026.  The opinion is presented here in its entirety, but with citations omitted. If you appreciate this episode, please subscribe. Thank you.

7 jun 202617 min